New lab working to develop new OCT technologies for retinal therapies


The new Christian Doppler Ophthalmic Image Analysis (OPTIMA) laboratory at the Medical University of Vienna (MedUni Vienna) in Austria is developing new optical coherence tomography (OCT) technologies and computer programs to produce optimal diagnosis and, for the first time, completely individual treatment plans.

Related: Advanced OCT: Next-gen OCT for the esophagus

Related: PRODUCT FOCUS: OCT systems for ophthalmology

The basic physics of OCT was developed at MedUni Vienna in the Centre for Medical Physics and Biomedical Technology, and then developed further and optimized in collaboration with the Eye Clinic for application in ophthalmology. With OCT, it is possible to identify disorders of the retina in high-resolution detail, and to do so at a very early stage and noninvasively. Using OCT, retinal disorders such as age-related macular degeneration (AMD), diabetes-related disorders, and vascular occlusions can be identified before any symptoms appear.

The OPTIMA laboratory opened officially on June 18, 2013, and it is the 11th Christian Doppler laboratory at MedUni Vienna. According to experts, the next OCT generation and analysis programs in development there could be operational in the clinic within two to three years.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS